Host Raj Mahapatra interviews Dr. Katie King, co-founder and CEO of BioOrbit, who shares her journey from childhood dreams of space to developing innovative drug delivery systems in microgravity, and the opportunities presented by AI in medicine.

Conversation Highlights:

• Introduction and Academic Journey
  Dr. King shares her journey from a childhood fascination with space to earning a PhD in nanomedicine and interning at NASA.
• Vision for Drug Production Using Space in Technology
  Dr. King outlines the concept of producing protein crystals in microgravity to enhance drug formulation, the unique advantages of space for crystallization, and the experience of developing their first automated protein crystallization prototype in a garage.
• Navigating Regulatory Challenges
  Dr. King breaks down the complexities of navigating regulatory environments in the pharmaceutical industry, particularly when introducing innovative space-based solutions to traditional drug development processes.
• Advancements in Personalized Medicine and Accessibility Initiatives
  The conversation emphasizes AI's role in optimizing research and underscores the importance of community and collaboration in the evolving technological landscape, highlighting the potential for innovations to democratize access to medications.

Meet the host and this episode’s guest:

• Dr. Katie King
• Raj Mahapatra

Listen to the episode here.  

This podcast is for general informational purposes and is not intended to provide and should not be relied on as legal advice. The information in this podcast is not tailored to a particularized situation or jurisdiction, may not reflect the current state of the law, and should not be considered a substitute for the advice of your own legal counsel. You should not consider this podcast an invitation to form an attorney-client relationship, and no attorney-client relationship is created by your use of this podcast. Wilson Sonsini disclaims all liability in respect to any actions taken or not taken based on the content of this podcast and notes that prior results do not guarantee a similar outcome. This podcast may be considered attorney advertising in certain jurisdictions.